These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6087192)

  • 1. Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitro.
    Rothman RB; Danks JA; Pert CB; Jacobson AE; Burke TR; Rice KC
    Neuropeptides; 1984 May; 4(3):261-8. PubMed ID: 6087192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric model.
    Rothman RB; Bowen WD; Bykov V; Schumacher UK; Pert CB; Jacobson AE; Burke TR; Rice KC
    Neuropeptides; 1984 May; 4(3):201-15. PubMed ID: 6087189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding site.
    Rothman RB; Danks JA; Herkenham M; Jacobson AE; Burke TR; Rice KC
    Neuropeptides; 1985 Jun; 6(3):227-37. PubMed ID: 2991807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine noncompetitively inhibits [3H]leucine enkephalin binding to membranes lacking type-II delta binding sites: evidence for a two-site allosteric model.
    Rothman RB; Pert CB; Jacobson AE; Burke TR; Rice KC
    Neuropeptides; 1984 May; 4(3):257-60. PubMed ID: 6087191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
    Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential coupling of mu-competitive and mu-noncompetitive delta opiate receptors to guanine nucleotide binding proteins in rat brain membranes.
    Bowen WD; Rodrigues PA; Wanzor TE; Jacobson AE; Rice KC
    Biochem Pharmacol; 1988 Feb; 37(3):467-72. PubMed ID: 2827687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine tolerance increases mu-noncompetitive delta binding sites.
    Rothman RB; Danks JA; Jacobson AE; Burke TR; Rice KC; Tortella FC; Holaday JW
    Eur J Pharmacol; 1986 May; 124(1-2):113-9. PubMed ID: 3013657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific binding.
    Rothman RB; Danks JA; Jacobson AE; Burke TR; Rice KC; Pert CB
    Neuropeptides; 1984 Jun; 4(4):311-7. PubMed ID: 6206435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA; Houghten R; Pasternak GW
    Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity labeling of delta-opiate receptors using [D-Ala2,Leu5,Cys6]enkephalin. Covalent attachment via thiol-disulfide exchange.
    Bowen WD; Hellewell SB; Kelemen M; Huey R; Stewart D
    J Biol Chem; 1987 Oct; 262(28):13434-9. PubMed ID: 2820969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular administration of superFIT and its enantiomer to rats: evidence for in vivo acylation of [3H]DADL binding sites.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC
    Neuropeptides; 1987 Apr; 9(3):207-10. PubMed ID: 3037427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted analysis of receptor-binding studies of [3H]-naloxone and [3H]-DADL: a reinterpretation of the Na+ effect.
    Loew GH; Toll L; Keys C
    Life Sci; 1983; 33 Suppl 1():163-6. PubMed ID: 6319855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta opioid receptors in vitro.
    Kim CH; Rothman RB; Jacobson AE; Mattson MV; Bykov V; Streaty RA; Klee WA; George C; Long JB; Rice KC
    J Med Chem; 1989 Jun; 32(6):1392-8. PubMed ID: 2542560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple interconvertible affinity states for the delta opioid agonist-receptor complex.
    Spain JW; Coscia CJ
    J Biol Chem; 1987 Jul; 262(19):8948-51. PubMed ID: 3036838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.
    Antkiewicz-Michaluk L; Havemann U; Vetulani J; Wellstein A; Kuschinsky K
    Life Sci; 1984 Jul; 35(4):347-55. PubMed ID: 6087059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric pentapeptide enkephalin: a novel probe of delta opiate receptors.
    Costa T; Shimohigashi Y; Krumins SA; Munson PJ; Rodbard D
    Life Sci; 1982 Oct; 31(15):1625-32. PubMed ID: 6292643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.